Recent studies have suggested that mutations in p53, a tumour suppressor gene, may be important in regulating the adaptive response of tumour cells to hypoxia by enhancing their survival and the release of pro-angiogenic factors (Kieser et al, 1994). This evidence concerns the gene TP53 and neoplasm.